Improving Diagnosis and Clinical Monitoring of Acid Sphingomyelinase Deficiency

Emerging Therapies: Efficacy and Safety Data from Phase 3 Trials

26 min · 26. maj 2022
Billede af episoden Emerging Therapies: Efficacy and Safety Data from Phase 3 Trials

Description

* Overview of olipudase alfa * Efficacy and safety of olipudase alfa from phase 2 and 3 trials

Comments

0

Be the first to comment

Sign up now and become a member of the Improving Diagnosis and Clinical Monitoring of Acid Sphingomyelinase Deficiency community!

Get Started

1 month for 9 kr.

Then 99 kr. / month · Cancel anytime

  • Podcasts kun på Podimo
  • 20 lydbogstimer pr. måned
  • Gratis podcasts